|
Invited Speakers:
|
|
· Kim C. Bush, Director, Life Sciences Partnerships, Global Health Program, Office of the President, The Bill & Melinda Gates Foundation · Dr Joachim Hombach, Senior Adviser, Immunization, Vaccines and Biologicals, World Health Organisation · Melissa Malhame, Head of Market Shaping, Policy & Performance, GAVI Alliance · Dr Jon Kim Andrus, Deputy Director, Pan American Health Organization · Xiaoming Yang, President, China National Biotec Group Company Limited · Dr Suresh Jadhav, Executive Director, Serum Institute of India (India) · Professor Jorge Kalil, Director & Chairman of the Board, Instituto Butantan (Brazil) · Dr Harish Iyer, Managing Director & CEO, Shantha Biotechnics Ltd (India) · Mahendra Suhardono, Director of Production, PT Bio Farma (Indonesia); President, DCVMN (Developing Countries Vaccine Manufacturers Network) · Dr Akira Homma, President, Strategy & Policy Council, Bio-Manguinhos / Fiocruz (Brazil) · Dr Yichen Lu, President, Haikou VTI Biological Institute (P.R. China); CEO, Vaccine Technology Inc (VTI) · Dr Samuel Ponce de León, General Director, Birmex (Laboratorios de Biológicos y Reactivos de México, S.A. de C.V) · Dr Luis Herrera-Martínez, Director General, CIGB (Center for Genetic Engineering & Biotechnology, Havana, Cuba) · Dr Abdul Muktadir, Managing Director, Incepta Pharmaceuticals Ltd (Bangladesh) · Dr Morena Makhoana, CEO, The Biovac Institute (South Africa) · Abel Di Gilio, President, Sinergium Biotech (Argentina) · Igor Krasilnikov, Vice Director of Science & Innovations, St. Petersburg Institute of Vaccines and Sera (Russia) · Professor Larisa G. Rudenko, MD, PhD, DSc, Head, Department of Virology, Institute of Experimental Medicine, St. Petersburg (Russia) · Dr Thomas F. Wierzba, Deputy Director General for Translational Research Division, International Vaccine Institute, Seoul Korea · K.V. Balasubramaniam, Managing Director, Indian Immunologicals Ltd (India) · Dr Rajiv Indravadan Modi, Managing Director, Cadila Pharmaceuticals (India) · Dr Allan P. Jarvis, Corporate Development Advisor, sanofi pasteur · Dr Klaus Stöhr, Vice President & Head, Global Policy, Novartis Vaccines & Diagnostics · Professor Ralf Rene Reinert, MD, DTM&H, Head, Europe Medicines Development Group & Scientific Affairs, Pfizer Vaccines, Specialty Care Business Unit · Samuel Ang MBA, MPA, LLB, Innovative Payer Partnership Lead, Global Market Access, Established Pharmaceuticals, Abbott Products Operations AG · John M. Clerici, Principal, Tiber Creek Partners, LLC · Ann M. Ginsberg, MD, PhD, Vice President, Scientific Affairs, Aeras · Abraham Shamir, Executive Director, Emerging Markets Vaccines & Biologics, Merck Manufacturing Division, Merck & Co, Inc · Burak Ergenoglu, Head of Strategic Planning & Portfolio Development, Sanofi Group Turkey · Jean-Marie Préaud, Senior Technical Officer, Pharmaceutical Operations, PATH · Russell P. "Rip" Wilson, Senior Vice President Business Development, Novavax · Dr Jerome Kim, HIV Vaccines Project Manager, US Military HIV Research Program, Walter Reed Army Institute of Research · Dr Dan Stinchcomb, Co-founder & CEO, Inviragen · Kamal A. Rashid, PhD, Associate Director Center for Integrated BioSystems & Research Professor, ADVS Department, Utah State University
|
|